50
Participants
Start Date
February 1, 2021
Primary Completion Date
February 1, 2023
Study Completion Date
February 1, 2023
Intravitreal injection of ranibizumab
"These patients were received three intravitreal injection of ranibizumab with one month interval. 3D-OCT by enhanced depth spectral-domain imaging (EDI-OCT) was done preoperative and a month after every injection.~All patients recieved topical anesthesia as 0.5 mg/0.05 ml , ranibizumab is injected 4 mm (3.5 mm in Pseudophakia) from the limbus intravitreally (in the lower temporal quadrant) by a needle (27gauge)."
Al-Azhar University, Asyut
Lead Sponsor
Egyptian Biomedical Research Network
NETWORK